Tumor-infiltrating FoxP3+ Tregs were associated with better survival in colorectal, head and neck, and esophageal cancers [21], and higher tumor-infiltrating Foxp3+ cells were associated with better OS in patients with resected gastric cancer [22]. This evidence concerns the gene FOXP3 and neoplasm.